1. Teva CEO Kåre Schultz Nabs Whopping $33M in First Full Year at the Helm

    Teva CEO Kåre Schultz Nabs Whopping $33M in First Full Year at the Helm

    If you thought Teva had gone big-time with its 2017 pay package for CEO Kåre Schultz, check out what it paid him in 2018. The Israeli drugmaker forked over (PDF) a whopping $32.5 million to its chief exec, nearly doubling the sum it paid him in 2017 and marking a fivefold increase over what it paid its last CEO, Erez Vigodman, the year prior...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned